Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05713695 · ClinicalTrials.gov registry record · NA

Supporting Treatment Access and Recovery Through Linkage and Support

A NA study of Substance Use Disorders and Mental Health Disorders, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
208
Enrollment target
1
Study location

NCT05713695 is a NA study of Substance Use Disorders and Mental Health Disorders that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 208 participants, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05713695, a NA study of Substance Use Disorders and Mental Health Disorders, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
208 participants
Enrollment target
1
Study location

Study Summary

This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving outcomes among individuals with CODs. We expect that individuals receiving MISSION versus linkage only will show greater improvement in treatment engagement, substance use, and mental health outcomes. This study will also concurrently conduct a process evaluation to inform sustainability and future implementation of such interventions.

Interventions

  • BEHAVIORAL Full MISSION
  • BEHAVIORAL Linkage Only Delivered by a Peer Specialist

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2023-05-24
Est. Completion 2026-09
Phase NA

What the Registry Record Tells You About NCT05713695

The ClinicalTrials.gov registry entry for NCT05713695 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Full MISSION is the first listed.

NCT05713695 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05713695 about?

NCT05713695 is a clinical study titled "Supporting Treatment Access and Recovery Through Linkage and Support". This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving ...

What is the current status of trial NCT05713695?

This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2023-05-24. Estimated completion is 2026-09.

What conditions does trial NCT05713695 study?

This clinical trial studies the following conditions: Substance Use Disorders, Mental Health Disorders.

What interventions are being tested in trial NCT05713695?

The interventions under investigation include: Full MISSION (BEHAVIORAL), Linkage Only Delivered by a Peer Specialist (BEHAVIORAL).

Who is sponsoring clinical trial NCT05713695?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05713695 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.